Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 85 | 2023 | 4471 | 8.120 |
Why?
|
Coronary Artery Disease | 54 | 2024 | 6403 | 3.500 |
Why?
|
Coronary Stenosis | 25 | 2023 | 794 | 3.470 |
Why?
|
Cardiac-Gated Imaging Techniques | 15 | 2019 | 139 | 3.150 |
Why?
|
Tomography, X-Ray Computed | 80 | 2024 | 20570 | 2.980 |
Why?
|
Coronary Vessels | 17 | 2023 | 3096 | 2.360 |
Why?
|
Radiation Dosage | 20 | 2018 | 1958 | 2.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 14 | 2018 | 1222 | 2.010 |
Why?
|
Plaque, Atherosclerotic | 12 | 2023 | 1533 | 1.750 |
Why?
|
Coronary Vessel Anomalies | 8 | 2019 | 307 | 1.590 |
Why?
|
Fractional Flow Reserve, Myocardial | 7 | 2024 | 323 | 1.530 |
Why?
|
Myocardial Perfusion Imaging | 9 | 2019 | 575 | 1.520 |
Why?
|
Predictive Value of Tests | 57 | 2023 | 15266 | 1.320 |
Why?
|
Chest Pain | 15 | 2022 | 1091 | 1.220 |
Why?
|
Tomography Scanners, X-Ray Computed | 3 | 2018 | 173 | 1.120 |
Why?
|
Tomography, Spiral Computed | 5 | 2014 | 273 | 1.010 |
Why?
|
Coronary Aneurysm | 2 | 2018 | 232 | 0.990 |
Why?
|
Acute Coronary Syndrome | 5 | 2018 | 2190 | 0.940 |
Why?
|
Heart Diseases | 10 | 2021 | 2781 | 0.940 |
Why?
|
Cardiac Imaging Techniques | 6 | 2023 | 267 | 0.910 |
Why?
|
Angiography | 7 | 2022 | 1595 | 0.880 |
Why?
|
Systole | 4 | 2016 | 936 | 0.860 |
Why?
|
Aortic Diseases | 4 | 2018 | 735 | 0.860 |
Why?
|
Hospitals, General | 3 | 2016 | 798 | 0.860 |
Why?
|
Vasodilator Agents | 5 | 2019 | 973 | 0.860 |
Why?
|
Aortic Valve | 9 | 2024 | 1955 | 0.840 |
Why?
|
Cardiology | 8 | 2023 | 1656 | 0.840 |
Why?
|
Vascular Diseases | 4 | 2019 | 1161 | 0.790 |
Why?
|
Scotoma | 1 | 2023 | 130 | 0.790 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2020 | 6 | 0.750 |
Why?
|
Arteries | 3 | 2023 | 1123 | 0.740 |
Why?
|
Aorta, Thoracic | 6 | 2019 | 1096 | 0.740 |
Why?
|
Thorax | 3 | 2016 | 555 | 0.710 |
Why?
|
Cardiomyopathy, Hypertrophic | 4 | 2023 | 1310 | 0.710 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2017 | 536 | 0.700 |
Why?
|
Societies, Medical | 15 | 2024 | 3905 | 0.690 |
Why?
|
Lipoproteins, HDL | 1 | 2024 | 676 | 0.650 |
Why?
|
Incidental Findings | 5 | 2017 | 697 | 0.650 |
Why?
|
Cardiology Service, Hospital | 2 | 2019 | 239 | 0.630 |
Why?
|
Emergency Service, Hospital | 10 | 2022 | 7879 | 0.620 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 8 | 2015 | 1068 | 0.620 |
Why?
|
Nitroglycerin | 1 | 2019 | 329 | 0.600 |
Why?
|
Humans | 196 | 2024 | 761504 | 0.600 |
Why?
|
Contrast Media | 17 | 2023 | 5311 | 0.590 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 997 | 0.580 |
Why?
|
Endoleak | 1 | 2018 | 111 | 0.580 |
Why?
|
Plasma | 1 | 2020 | 586 | 0.570 |
Why?
|
Arrhythmias, Cardiac | 5 | 2019 | 2244 | 0.560 |
Why?
|
Substance Abuse, Intravenous | 3 | 2018 | 529 | 0.550 |
Why?
|
Coronary Circulation | 5 | 2015 | 1569 | 0.550 |
Why?
|
Documentation | 2 | 2013 | 897 | 0.550 |
Why?
|
Magnetic Resonance Imaging | 19 | 2024 | 36426 | 0.550 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2017 | 278 | 0.540 |
Why?
|
Accidental Falls | 1 | 2024 | 1068 | 0.520 |
Why?
|
Middle Aged | 88 | 2024 | 220895 | 0.510 |
Why?
|
Robotics | 1 | 2022 | 819 | 0.510 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 395 | 0.510 |
Why?
|
Endocarditis | 2 | 2021 | 348 | 0.510 |
Why?
|
Pericardium | 2 | 2018 | 675 | 0.500 |
Why?
|
Heart Defects, Congenital | 7 | 2023 | 4671 | 0.500 |
Why?
|
Algorithms | 11 | 2020 | 14031 | 0.500 |
Why?
|
Hemoptysis | 1 | 2016 | 152 | 0.490 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 173 | 0.490 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.490 |
Why?
|
Health Records, Personal | 2 | 2013 | 127 | 0.490 |
Why?
|
Male | 105 | 2024 | 360804 | 0.490 |
Why?
|
Vasodilation | 1 | 2019 | 962 | 0.480 |
Why?
|
Registries | 12 | 2019 | 8224 | 0.480 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 219 | 0.470 |
Why?
|
Heart Ventricles | 8 | 2023 | 3807 | 0.470 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2019 | 1553 | 0.470 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 877 | 0.470 |
Why?
|
Heart Valve Diseases | 4 | 2024 | 1027 | 0.460 |
Why?
|
Adenosine | 4 | 2011 | 808 | 0.450 |
Why?
|
Aorta | 4 | 2021 | 2042 | 0.450 |
Why?
|
Coronary Occlusion | 1 | 2016 | 304 | 0.430 |
Why?
|
Electrocardiography | 13 | 2019 | 6377 | 0.430 |
Why?
|
Reproducibility of Results | 21 | 2019 | 20098 | 0.430 |
Why?
|
Sinus of Valsalva | 3 | 2018 | 60 | 0.420 |
Why?
|
Triage | 3 | 2018 | 986 | 0.420 |
Why?
|
Myocardial Infarction | 10 | 2023 | 11460 | 0.420 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2014 | 162 | 0.410 |
Why?
|
Radiation, Ionizing | 1 | 2013 | 251 | 0.410 |
Why?
|
Aortic Valve Stenosis | 6 | 2024 | 2001 | 0.410 |
Why?
|
Atherosclerosis | 4 | 2015 | 3408 | 0.410 |
Why?
|
Radiographic Image Enhancement | 6 | 2014 | 876 | 0.410 |
Why?
|
Radiology | 6 | 2023 | 2113 | 0.400 |
Why?
|
Female | 98 | 2024 | 392644 | 0.400 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2018 | 1050 | 0.400 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.400 |
Why?
|
Computer Terminals | 1 | 2011 | 41 | 0.390 |
Why?
|
Heart | 9 | 2020 | 4404 | 0.390 |
Why?
|
Aged | 58 | 2024 | 169289 | 0.370 |
Why?
|
Radiology Information Systems | 2 | 2014 | 529 | 0.360 |
Why?
|
Iopamidol | 5 | 2014 | 186 | 0.360 |
Why?
|
Retrospective Studies | 38 | 2024 | 80636 | 0.360 |
Why?
|
Pacemaker, Artificial | 1 | 2016 | 807 | 0.360 |
Why?
|
Diastole | 1 | 2013 | 782 | 0.360 |
Why?
|
Radiation Injuries | 4 | 2015 | 1189 | 0.350 |
Why?
|
Exercise Test | 6 | 2018 | 2127 | 0.350 |
Why?
|
Guideline Adherence | 4 | 2018 | 2220 | 0.340 |
Why?
|
Image Enhancement | 4 | 2019 | 2885 | 0.340 |
Why?
|
Unnecessary Procedures | 1 | 2013 | 415 | 0.340 |
Why?
|
Constriction, Pathologic | 5 | 2024 | 1096 | 0.340 |
Why?
|
Cardiac Resynchronization Therapy | 3 | 2020 | 555 | 0.330 |
Why?
|
Radiation Protection | 4 | 2014 | 424 | 0.330 |
Why?
|
Adipose Tissue | 3 | 2023 | 3312 | 0.320 |
Why?
|
Myocardium | 4 | 2014 | 4726 | 0.320 |
Why?
|
Sensitivity and Specificity | 17 | 2019 | 14666 | 0.320 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 695 | 0.320 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2019 | 1428 | 0.310 |
Why?
|
Practice Guidelines as Topic | 7 | 2020 | 7390 | 0.310 |
Why?
|
Prognosis | 23 | 2023 | 29625 | 0.310 |
Why?
|
Echocardiography | 13 | 2021 | 4989 | 0.300 |
Why?
|
Diagnostic Imaging | 8 | 2023 | 3530 | 0.300 |
Why?
|
Artifacts | 5 | 2024 | 1911 | 0.300 |
Why?
|
Feasibility Studies | 8 | 2016 | 5247 | 0.290 |
Why?
|
Boston | 10 | 2019 | 9326 | 0.290 |
Why?
|
Workload | 1 | 2013 | 844 | 0.290 |
Why?
|
Comprehension | 1 | 2013 | 621 | 0.290 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 250 | 0.290 |
Why?
|
Heart Neoplasms | 2 | 2024 | 362 | 0.290 |
Why?
|
Medical Records Systems, Computerized | 1 | 2013 | 1192 | 0.280 |
Why?
|
Evidence-Based Medicine | 4 | 2024 | 3688 | 0.280 |
Why?
|
Data Collection | 1 | 2016 | 3322 | 0.280 |
Why?
|
Risk Assessment | 20 | 2021 | 23995 | 0.280 |
Why?
|
Massachusetts | 9 | 2020 | 8830 | 0.270 |
Why?
|
Cardiovascular System | 3 | 2021 | 834 | 0.270 |
Why?
|
Calcium | 3 | 2022 | 5722 | 0.270 |
Why?
|
Hemodynamics | 4 | 2019 | 4159 | 0.270 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2018 | 696 | 0.270 |
Why?
|
Cardiovascular Abnormalities | 2 | 2017 | 143 | 0.260 |
Why?
|
Adult | 42 | 2023 | 221177 | 0.260 |
Why?
|
Consensus | 11 | 2023 | 3123 | 0.260 |
Why?
|
Aortic Coarctation | 2 | 2018 | 275 | 0.250 |
Why?
|
Magnetic Resonance Angiography | 4 | 2023 | 1432 | 0.250 |
Why?
|
Calcinosis | 4 | 2016 | 1469 | 0.250 |
Why?
|
Gout | 2 | 2024 | 621 | 0.240 |
Why?
|
Lipoproteins, LDL | 2 | 2020 | 642 | 0.240 |
Why?
|
Referral and Consultation | 3 | 2016 | 3600 | 0.230 |
Why?
|
Equipment Design | 4 | 2017 | 3510 | 0.230 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2183 | 0.230 |
Why?
|
Severity of Illness Index | 17 | 2020 | 15842 | 0.230 |
Why?
|
Internet | 1 | 2016 | 3092 | 0.220 |
Why?
|
Atrial Fibrillation | 4 | 2024 | 5127 | 0.220 |
Why?
|
Bioprosthesis | 2 | 2019 | 591 | 0.220 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2023 | 42 | 0.210 |
Why?
|
Diagnosis, Differential | 12 | 2020 | 12974 | 0.210 |
Why?
|
Apolipoprotein A-I | 1 | 2024 | 299 | 0.200 |
Why?
|
Cardiomyopathies | 3 | 2019 | 1964 | 0.200 |
Why?
|
Overweight | 1 | 2013 | 2417 | 0.200 |
Why?
|
Myocardial Ischemia | 3 | 2019 | 2113 | 0.200 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2018 | 352 | 0.200 |
Why?
|
United States | 24 | 2024 | 72334 | 0.190 |
Why?
|
Echocardiography, Stress | 2 | 2017 | 134 | 0.190 |
Why?
|
Pulmonary Embolism | 5 | 2020 | 2567 | 0.190 |
Why?
|
Teratoma | 1 | 2024 | 404 | 0.190 |
Why?
|
Prospective Studies | 20 | 2023 | 54425 | 0.190 |
Why?
|
Telecommunications | 1 | 2021 | 80 | 0.190 |
Why?
|
Heart Valve Prosthesis | 2 | 2020 | 1462 | 0.190 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3357 | 0.180 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2013 | 882 | 0.180 |
Why?
|
Cardiovascular Diseases | 6 | 2019 | 15500 | 0.180 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1303 | 0.180 |
Why?
|
Renal Artery | 1 | 2022 | 351 | 0.180 |
Why?
|
ROC Curve | 5 | 2016 | 3579 | 0.180 |
Why?
|
Prevalence | 10 | 2019 | 15732 | 0.180 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2011 | 2118 | 0.180 |
Why?
|
Atrial Septum | 2 | 2010 | 60 | 0.180 |
Why?
|
Heart Rate | 4 | 2013 | 4195 | 0.180 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 33 | 0.180 |
Why?
|
Uric Acid | 2 | 2024 | 807 | 0.180 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5440 | 0.170 |
Why?
|
Risk Factors | 27 | 2022 | 74206 | 0.170 |
Why?
|
Atrial Appendage | 2 | 2024 | 283 | 0.170 |
Why?
|
Stroke Volume | 5 | 2020 | 5496 | 0.170 |
Why?
|
Case-Control Studies | 7 | 2024 | 22176 | 0.170 |
Why?
|
Radiotherapy | 1 | 2006 | 1499 | 0.170 |
Why?
|
Body Mass Index | 5 | 2018 | 12953 | 0.170 |
Why?
|
Embolism | 1 | 2023 | 399 | 0.170 |
Why?
|
Anemia, Hemolytic | 1 | 2020 | 162 | 0.170 |
Why?
|
Echocardiography, Doppler | 3 | 2018 | 897 | 0.170 |
Why?
|
Administration, Sublingual | 1 | 2019 | 59 | 0.170 |
Why?
|
Quality Improvement | 2 | 2020 | 3801 | 0.170 |
Why?
|
Treatment Outcome | 17 | 2022 | 64680 | 0.170 |
Why?
|
Hematuria | 1 | 2020 | 233 | 0.160 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Pulmonary Artery | 3 | 2016 | 1927 | 0.160 |
Why?
|
Arterial Occlusive Diseases | 1 | 2023 | 748 | 0.160 |
Why?
|
Tablets | 1 | 2019 | 148 | 0.160 |
Why?
|
Electronic Health Records | 1 | 2016 | 4811 | 0.160 |
Why?
|
Postoperative Complications | 3 | 2019 | 15631 | 0.160 |
Why?
|
Coronary Disease | 4 | 2015 | 5914 | 0.160 |
Why?
|
Urban Health | 1 | 2021 | 532 | 0.160 |
Why?
|
Chlamydia trachomatis | 1 | 2020 | 239 | 0.160 |
Why?
|
Septal Occluder Device | 1 | 2019 | 125 | 0.160 |
Why?
|
Obesity | 3 | 2018 | 12947 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2020 | 462 | 0.150 |
Why?
|
Blood Flow Velocity | 3 | 2018 | 1371 | 0.150 |
Why?
|
Ventricular Function, Left | 5 | 2020 | 3879 | 0.150 |
Why?
|
Hypertrophy, Right Ventricular | 2 | 2018 | 108 | 0.150 |
Why?
|
North America | 4 | 2023 | 1276 | 0.150 |
Why?
|
Aortography | 2 | 2016 | 421 | 0.150 |
Why?
|
Thoracic Injuries | 1 | 2020 | 288 | 0.150 |
Why?
|
Weill-Marchesani Syndrome | 1 | 2017 | 6 | 0.150 |
Why?
|
Psoas Muscles | 1 | 2018 | 66 | 0.150 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 330 | 0.150 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1489 | 0.150 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2010 | 451 | 0.150 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58976 | 0.140 |
Why?
|
Vaginal Smears | 1 | 2020 | 499 | 0.140 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2019 | 123 | 0.140 |
Why?
|
Ferrosoferric Oxide | 1 | 2018 | 348 | 0.140 |
Why?
|
Patient Selection | 1 | 2019 | 4244 | 0.140 |
Why?
|
Occupational Exposure | 2 | 2020 | 1813 | 0.140 |
Why?
|
Positron-Emission Tomography | 4 | 2019 | 6485 | 0.140 |
Why?
|
Arterio-Arterial Fistula | 1 | 2016 | 20 | 0.140 |
Why?
|
Ventricular Pressure | 1 | 2018 | 210 | 0.140 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 713 | 0.140 |
Why?
|
Time Factors | 11 | 2021 | 39967 | 0.140 |
Why?
|
Intracranial Aneurysm | 1 | 2006 | 1285 | 0.140 |
Why?
|
Chlamydia Infections | 1 | 2020 | 365 | 0.140 |
Why?
|
Aerosols | 1 | 2019 | 635 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 2 | 2015 | 1555 | 0.130 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2017 | 164 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2020 | 443 | 0.130 |
Why?
|
Area Under Curve | 3 | 2015 | 1638 | 0.130 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2219 | 0.130 |
Why?
|
Ventricular Remodeling | 3 | 2020 | 1267 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 213 | 0.130 |
Why?
|
Cryptorchidism | 1 | 2016 | 151 | 0.130 |
Why?
|
Regional Blood Flow | 2 | 2016 | 1496 | 0.120 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1204 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2010 | 0.120 |
Why?
|
Smad4 Protein | 1 | 2016 | 191 | 0.120 |
Why?
|
Hand Deformities, Congenital | 1 | 2016 | 174 | 0.120 |
Why?
|
Vascular Resistance | 1 | 2018 | 930 | 0.120 |
Why?
|
Vagina | 1 | 2020 | 838 | 0.120 |
Why?
|
Arm | 1 | 2018 | 589 | 0.120 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 393 | 0.120 |
Why?
|
Health Personnel | 2 | 2020 | 3335 | 0.120 |
Why?
|
Disposable Equipment | 1 | 2014 | 46 | 0.120 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2014 | 22 | 0.110 |
Why?
|
Ventricular Function, Right | 2 | 2018 | 617 | 0.110 |
Why?
|
Follow-Up Studies | 13 | 2018 | 39106 | 0.110 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 807 | 0.110 |
Why?
|
Arteritis | 1 | 2016 | 158 | 0.110 |
Why?
|
Radiologic Health | 1 | 2013 | 4 | 0.110 |
Why?
|
Preoperative Care | 3 | 2024 | 2242 | 0.110 |
Why?
|
Heroin Dependence | 1 | 2014 | 172 | 0.110 |
Why?
|
Aortic Valve Insufficiency | 2 | 2019 | 576 | 0.110 |
Why?
|
Foramen Ovale, Patent | 1 | 2016 | 208 | 0.110 |
Why?
|
Sarcoidosis | 1 | 2019 | 521 | 0.110 |
Why?
|
Observer Variation | 2 | 2017 | 2606 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2759 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2017 | 959 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 719 | 0.110 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1972 | 0.110 |
Why?
|
Acute Disease | 4 | 2017 | 7237 | 0.110 |
Why?
|
Probability | 4 | 2022 | 2477 | 0.110 |
Why?
|
Aortic Rupture | 1 | 2016 | 319 | 0.100 |
Why?
|
American Heart Association | 1 | 2017 | 1039 | 0.100 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 613 | 0.100 |
Why?
|
Exercise Tolerance | 1 | 2018 | 836 | 0.100 |
Why?
|
Aortic Aneurysm | 1 | 2017 | 648 | 0.100 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 589 | 0.100 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2018 | 628 | 0.100 |
Why?
|
DNA Helicases | 1 | 2018 | 851 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
Aneurysm | 1 | 2015 | 337 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 750 | 0.100 |
Why?
|
Fluoroscopy | 1 | 2016 | 947 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
Mitral Valve | 1 | 2020 | 1465 | 0.100 |
Why?
|
Pandemics | 3 | 2022 | 8654 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 3245 | 0.100 |
Why?
|
Prosthesis Design | 1 | 2019 | 2115 | 0.100 |
Why?
|
Musculoskeletal Diseases | 1 | 2018 | 598 | 0.100 |
Why?
|
Losartan | 1 | 2013 | 265 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1186 | 0.100 |
Why?
|
Tricuspid Valve | 1 | 2014 | 410 | 0.100 |
Why?
|
Pilot Projects | 4 | 2019 | 8631 | 0.100 |
Why?
|
Diffusion of Innovation | 3 | 2021 | 728 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2018 | 1493 | 0.100 |
Why?
|
Device Removal | 1 | 2016 | 630 | 0.090 |
Why?
|
Purines | 1 | 2015 | 607 | 0.090 |
Why?
|
Growth Disorders | 1 | 2016 | 655 | 0.090 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 534 | 0.090 |
Why?
|
Thoracic Surgery | 1 | 2017 | 722 | 0.090 |
Why?
|
Tissue Scaffolds | 1 | 2018 | 934 | 0.090 |
Why?
|
Warfarin | 1 | 2019 | 1483 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 491 | 0.090 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 431 | 0.090 |
Why?
|
Tachycardia, Ventricular | 1 | 2019 | 1304 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 840 | 0.090 |
Why?
|
Ultrasonography | 4 | 2021 | 5972 | 0.090 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 436 | 0.090 |
Why?
|
Ultrasonography, Interventional | 2 | 2015 | 1496 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 1961 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2015 | 740 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2078 | 0.090 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 625 | 0.090 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 799 | 0.080 |
Why?
|
Tomography | 2 | 2024 | 411 | 0.080 |
Why?
|
Adiposity | 2 | 2018 | 1878 | 0.080 |
Why?
|
Stents | 2 | 2019 | 3179 | 0.080 |
Why?
|
Health Care Costs | 2 | 2018 | 3242 | 0.080 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2014 | 474 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2016 | 1315 | 0.080 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1515 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2018 | 1188 | 0.080 |
Why?
|
Abdomen | 1 | 2014 | 1128 | 0.080 |
Why?
|
Hypertension, Pulmonary | 2 | 2016 | 1578 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2013 | 851 | 0.080 |
Why?
|
Odds Ratio | 3 | 2015 | 9646 | 0.080 |
Why?
|
HIV Infections | 3 | 2022 | 17351 | 0.070 |
Why?
|
Radiometry | 1 | 2013 | 813 | 0.070 |
Why?
|
Radiography, Thoracic | 3 | 2020 | 1302 | 0.070 |
Why?
|
Respiratory System | 1 | 2011 | 563 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2018 | 1868 | 0.070 |
Why?
|
Inflammation | 4 | 2023 | 10773 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1866 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2013 | 829 | 0.070 |
Why?
|
Cicatrix | 1 | 2013 | 798 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2072 | 0.070 |
Why?
|
Young Adult | 8 | 2020 | 59243 | 0.070 |
Why?
|
Linear Models | 3 | 2012 | 5871 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.070 |
Why?
|
Stroke | 2 | 2019 | 9757 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1390 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2014 | 1121 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2942 | 0.070 |
Why?
|
Uganda | 2 | 2022 | 1332 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 2 | 2017 | 1086 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2012 | 6228 | 0.070 |
Why?
|
Tomography, Optical Coherence | 2 | 2018 | 2917 | 0.060 |
Why?
|
Clinical Competence | 3 | 2016 | 4792 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1007 | 0.060 |
Why?
|
Medicare | 2 | 2021 | 6770 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2019 | 3233 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2021 | 4527 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12059 | 0.060 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2382 | 0.060 |
Why?
|
Chronic Disease | 2 | 2016 | 9318 | 0.060 |
Why?
|
Phenotype | 3 | 2018 | 16591 | 0.060 |
Why?
|
Gadolinium | 2 | 2023 | 960 | 0.060 |
Why?
|
Pyrazoles | 1 | 2015 | 2009 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4174 | 0.060 |
Why?
|
Reference Values | 1 | 2011 | 4920 | 0.060 |
Why?
|
Anticoagulants | 1 | 2019 | 4812 | 0.060 |
Why?
|
Artificial Intelligence | 3 | 2022 | 2578 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2373 | 0.060 |
Why?
|
Dyspnea | 3 | 2016 | 1347 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5796 | 0.050 |
Why?
|
Logistic Models | 2 | 2015 | 13255 | 0.050 |
Why?
|
Forecasting | 1 | 2012 | 2928 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3429 | 0.050 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2651 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3133 | 0.050 |
Why?
|
Phlebography | 1 | 2023 | 326 | 0.050 |
Why?
|
Electric Countershock | 1 | 2024 | 533 | 0.050 |
Why?
|
Cerebral Angiography | 1 | 2006 | 1281 | 0.050 |
Why?
|
Occupational Health | 2 | 2020 | 806 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 2243 | 0.050 |
Why?
|
Sex Factors | 3 | 2020 | 10552 | 0.040 |
Why?
|
Societies, Scientific | 1 | 2021 | 222 | 0.040 |
Why?
|
Pamphlets | 1 | 2020 | 71 | 0.040 |
Why?
|
Software | 1 | 2014 | 4434 | 0.040 |
Why?
|
Age Factors | 2 | 2016 | 18395 | 0.040 |
Why?
|
Radiography | 2 | 2024 | 6965 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2020 | 437 | 0.040 |
Why?
|
Animals | 5 | 2024 | 168459 | 0.040 |
Why?
|
Urinalysis | 1 | 2020 | 368 | 0.040 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2019 | 122 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12128 | 0.040 |
Why?
|
Syncope | 1 | 2021 | 427 | 0.040 |
Why?
|
Heart Atria | 1 | 2024 | 1345 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3267 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3416 | 0.040 |
Why?
|
Heart Failure | 2 | 2020 | 11669 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Mutation | 3 | 2018 | 30052 | 0.040 |
Why?
|
Fibrosis | 2 | 2016 | 2049 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5840 | 0.040 |
Why?
|
Extremities | 1 | 2023 | 867 | 0.040 |
Why?
|
Muscle Weakness | 1 | 2020 | 412 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2011 | 9000 | 0.040 |
Why?
|
Actomyosin | 1 | 2018 | 109 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6484 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2014 | 5492 | 0.030 |
Why?
|
Survival Rate | 3 | 2016 | 12725 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2016 | 12341 | 0.030 |
Why?
|
Bioreactors | 1 | 2018 | 247 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 588 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6425 | 0.030 |
Why?
|
Facies | 1 | 2016 | 222 | 0.030 |
Why?
|
Hydrodynamics | 1 | 2016 | 168 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 456 | 0.030 |
Why?
|
Adolescent | 4 | 2020 | 88319 | 0.030 |
Why?
|
Marfan Syndrome | 1 | 2017 | 236 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1202 | 0.030 |
Why?
|
Health Status | 2 | 2018 | 4077 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36192 | 0.030 |
Why?
|
Advisory Committees | 1 | 2019 | 787 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.030 |
Why?
|
Child, Preschool | 2 | 2017 | 42230 | 0.030 |
Why?
|
Risk | 2 | 2020 | 9610 | 0.030 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 276 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 492 | 0.030 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 399 | 0.030 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2015 | 148 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2018 | 699 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2018 | 2469 | 0.030 |
Why?
|
Cadaver | 1 | 2018 | 1358 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 679 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14605 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 2018 | 700 | 0.030 |
Why?
|
Perfusion | 1 | 2018 | 1373 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26198 | 0.030 |
Why?
|
Lung | 3 | 2016 | 10000 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13506 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2014 | 490 | 0.030 |
Why?
|
Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2006 | 2895 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 790 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 983 | 0.020 |
Why?
|
Incidence | 3 | 2015 | 21353 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2495 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1866 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4021 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1674 | 0.020 |
Why?
|
Troponin T | 1 | 2016 | 780 | 0.020 |
Why?
|
Child | 4 | 2023 | 80153 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2015 | 627 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 463 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 981 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 684 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2330 | 0.020 |
Why?
|
Materials Testing | 1 | 2014 | 863 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2787 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2020 | 2180 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2391 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2510 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2018 | 1726 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13380 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2009 | 182 | 0.020 |
Why?
|
Quality of Life | 2 | 2018 | 13367 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4542 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12148 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2628 | 0.020 |
Why?
|
RNA Interference | 1 | 2018 | 2831 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2927 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2188 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2909 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 709 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3429 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2014 | 1722 | 0.020 |
Why?
|
Histones | 1 | 2018 | 2580 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2979 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1618 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2735 | 0.020 |
Why?
|
Chromatin | 1 | 2018 | 2960 | 0.020 |
Why?
|
Health Expenditures | 1 | 2018 | 2366 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2526 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4853 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8465 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6534 | 0.020 |
Why?
|
Rest | 1 | 2010 | 918 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4063 | 0.010 |
Why?
|
Hepatitis C | 1 | 2014 | 1584 | 0.010 |
Why?
|
Survivors | 1 | 2015 | 2371 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.010 |
Why?
|
Cause of Death | 1 | 2015 | 3683 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15601 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4398 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14414 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10090 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12463 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2751 | 0.010 |
Why?
|
Health Policy | 1 | 2014 | 2684 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23742 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3249 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6240 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5368 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2014 | 5294 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18252 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8540 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9177 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23445 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41487 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81525 | 0.010 |
Why?
|